...
机译:通过肽阳离子脂质体纳米载体共同递送白藜芦醇和P53基因,用于宫颈癌和乳腺癌细胞的协同治疗
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Dalian Minzu Univ Minist Educ Key Lab Biotechnol &
Bioresources Utilizat Dalian 116600 Peoples;
Co-delivery; Resveratrol; P53 gene; Synergistic effects; Cancer therapy;
机译:通过肽阳离子脂质体纳米载体共同递送白藜芦醇和P53基因,用于宫颈癌和乳腺癌细胞的协同治疗
机译:使用可生物降解的PEG-PLA胶束共同递送多西紫杉醇和多柔比星,用于治疗具有协同抗肿瘤作用的乳腺癌
机译:表观遗传和抗癌药物序贯治疗克服乳腺癌细胞耐药性的高度协同作用是通过激活p21基因表达而介导的,从而导致G2 / M周期停滞
机译:智能抗整合蛋白共轭阳离子蛋白纳米载体的制备用于治疗HER2乳腺癌
机译:白藜芦醇增强了MDA-MB-231和耐紫杉醇的MDA-MB-231乳腺癌细胞中的紫杉醇治疗。
机译:组合原花青素和白藜芦醇协同抑制人类乳腺癌细胞并影响表观遗传介导机制
机译:顺序治疗与表观遗传和抗癌药物克服乳腺癌细胞耐药性的高度协同效应是通过激活介导的P21庚烷段导致G2 / M循环骤停介导